Castle Biosciences Inc.

27.50
0.44 (1.63%)
At close: Jan 29, 2025, 3:59 PM
27.49
-0.04%
After-hours Jan 29, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -57.47M -67.14M -31.29M -10.28M 5.28M -6.37M -12.37M
Depreciation & Amortization 12.33M 10.54M 3.41M 472.00K 358.00K 323.02K 310.82K
Stock-Based Compensation 51.22M 36.32M 21.74M 8.31M 1.25M 293.64K 108.70K
Other Working Capital 6.55M 7.31M 384.00K 8.30M 738.00K 1.43M -467.65K
Other Non-Cash Items -4.86M -19.50M 33.04M 823.00K 2.37M 542.37K 520.23K
Deferred Income Tax -223.00K -1.88M -8.74M 1.40M -2.28M 272.42K -163.29K
Change in Working Capital -6.63M -7.00K -4.10M 9.15M 44.00K -7.36M -640.51K
Operating Cash Flow -5.63M -41.66M -18.98M 9.87M 7.01M -12.29M -12.23M
Capital Expenditures -13.62M -5.63M -3.48M -4.75M -937.00K -277.04K -494.85K
Acquisitions n/a -26.97M -63.18M 3.00K n/a n/a n/a
Purchase of Investments -189.07M -134.69M n/a n/a n/a n/a n/a
Sales Maturities Of Investments 186.50M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 13.00K 742.00K 10.00K 3.00K n/a n/a n/a
Investing Cash Flow -16.18M -166.54M -66.66M -4.75M -937.00K -277.04K -494.85K
Debt Repayment -142.00K -122.00K -8.00K -27.36M 20.92M 5.42M 8.57M
Common Stock Repurchased -5.13M -1.69M -781.00K n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -2.16M 1.64M 5.43M 3.21M 1.44M 10.38M 292.71K
Financial Cash Flow -2.30M 1.51M 5.42M 305.89M 88.29M 15.84M 8.87M
Net Cash Flow -24.11M -206.69M -80.22M 311.01M 94.37M 3.27M -3.86M
Free Cash Flow -19.25M -47.29M -22.47M 5.11M 6.08M -12.57M -12.73M

Create Price Alert on CSTL

Your price alert will notify you when the stock price is above 27.50.

Add to Watchlist